baber/WOPTO huggingface dataset:
Patent NZ-581804-A (NZ)
Title: Bioactive hydrogel compositions for regenerating connective tissue
Inventor: HILL RONALD STEWART
IPC: A61K35/32
Filed: 2004-10-22
Abstract: Provided is a method for attaching a first connective tissue to a second connective tissue at a point of attachment in a non-human animal, the method comprising: a) coating at least a portion of at least one of said first and second connective tissue with a bioactive hydrogel matrix comprising: i. a polypeptide; and ii. a long chain carbohydrate; b) contacting said first connective tissue to said second connective tissue at a point of attachment; and c) attaching said first connective tissue to said second connective tissue by at least one of suturing, stapling, or gluing. The polypeptide can be collagen, keratin or aggrecan, among others and the polysaccharide can be dextran, dextrin, starch, cellulose, chitin or chitosan, among others.
Patent NZ-590969-A (NZ)
Title: Dishwasher comprising a sorption drying device
Inventor: JERG HELMUT
IPC: B01D53/26
Filed: 2009-08-07
Abstract: Disclosed is a dishwasher which includes a washing container with a sorption drying system for drying items to be washed. The sorption drying system has a sorption container with reversibly dehydratable granular solid sorption material inside. The sorption container is connected to the washing container by an air-guiding channel for the generation of an air flow. The sorption material is able to absorb a quantity of moisture transported in the air flow. The granular solid particles of the sorption material have a grain size of between 1 and 6 mm and a fill height corresponding to at least 5 times their grain size.
Patent NZ-591609-A (NZ)
Title: Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
Inventor: PEI ZHONGHAU
IPC: A61K31/135
Filed: 2006-08-25
Abstract: Disclosed are trans-6-(phenyl)cyclohex-3-en-1-amine / trans-2-(phenyl)cyclohex-4-enyl-amine derivatives as represented by the general formula (I), wherein the substituents are as disclosed herein. Representative compounds include trans-6-(2-chlorophenyl)cyclohex-3-en-1-amine, trans-6-(2,4-dichlorophenyl)cyclohex-3-enyl-amine, 4-{ [trans-5-amino-4-(2,4-dichlorophenyl)-2-pyridin-3-ylcyclohex-1 -en-1-yl]methoxy} benzonitrile, trans-methyl 3-{ { 5-amino-4-(2,4-dichlorophenyl)-2-pyridin-3-ylcyclohex-1-en-1-yl]methoxy} benzoate, trans-3-(phenoxymethyl)-6-(2,4,5-trifluorophenyl)cyclohex-3-en-1-amine, trans-3-{ [4-(methylsulfonyI)phenoxy] methyl} -6-(2,4,5-trifluorophenyl)cyclohex-3-en-1-amine, N-(3-{ [trans-5-amino-4-(2,4,5-trifluorophenyl)cyclohex-1-en-1-yl)methoxy } phenyl)acetamide, 3-{ [trans-5-amino-4-(2,4,5-trifluorophenyl)cyclohex-1-en-1-yl]methoxy} -4-fluorobenzoic acid, trans-3-{ [3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]methyl} -6-(2,4,5-trifluorophenyl)cyclohex-3-en-1-amine and trans-3-[(4-acetylpiperazin-1-yI)methyl]-6-(2,4,5-trifluorophenyl)cyclohex -3-en-1-amine. Further disclosed is a pharmaceutical composition which comprises a therapeutically effective amount of a compound as defined above, in combination with a pharmaceutically suitable carrier for the treatment of diseases selected from the group consisting of cardiovascular disease, atherosclerosis, cerebrovascular diseases, diseases and disorders of the central nervous system, schizophrenia, anxiety, bipolar disease, depression, insomnia, cognitive disorders, gastrointestinal diseases and disorders, cancer, inflammation and inflammatory diseases, respiratory diseases and disorders, musculo-skeletal disorders, osteoporosis, menopausal symptoms, periodontal diseases, gingivitis, and various immunomodulatory diseases.
Patent NZ-595751-A (NZ)
Title: Dental implant with a temporary magnetic screw
Inventor: BAMBINI FABRIZIO
IPC: A61C8/00
Filed: 2010-04-15
Abstract: The present application relates to an apparatus for dental implants that incorporate a temporary screw (4) made of NdFeB permanent magnet to generate, for the entire permanence in the cavity obtained in the patient's bone, a magnetic field suitable to favor the sudden healing of the bone.
Patent NZ-599237-A (NZ)
Title: Sirna compounds comprising terminal substitutions
Inventor: AVKIN-NACHUM SHARON
IPC: A61K31/713
Filed: 2010-11-25
Abstract: Patent No. 599237 Disclosed is a double stranded nucleic acid molecule having structure (A) set forth below: (A) 5’ N1-(N)x - Z 3’ (antisense strand) 3’ Z’-N2-(N’)y –z” 5’ (sense strand) wherein each of N2, N and N’ is an unmodified or modified ribonucleotide, or an unconventional moiety; wherein each of (N)x and (N’)y is an oligonucleotide in which each consecutive N or N’ is joined to the adjacent N or N’ by a covalent bond; wherein each of x and y is independently an integer between 17 and 39; wherein the sequence of (N’)y has complementarity to the sequence of (N)x and the sequence of (N)x has complementarity to a consecutive sequence in a target RNA; wherein N1 is covalently bound to (N)x and forms a Watson-Crick base pair with N2; wherein N1 is not complementary to the corresponding nucleotide in the target RNA; wherein N1 is selected from the group consisting of natural or modified adenosine, and deoxyadenosine when the corresponding nucleotide in the target RNA sequence is adenosine; or N1 is selected from the group consisting of natural or modified adenosine, deoxyadenosine, deoxyuridine, deoxythymidine and ribothymidine when the corresponding nucleotide in the target RNA sequence is cytidine; or N1 is selected from the group consisting of natural or modified adenosine, deoxyadenosine, uridine, deoxyuridine, ribothymidine and deoxythymidine when the corresponding nucleotide in the target RNA sequence is guanosine; or N1 is selected from the group consisting of natural or modified uridine, deoxyuridine, ribothymidine and deoxythymidine when the corresponding nucleotide in the target RNA sequence is uridine; wherein z” may be present or absent, but if present is a capping moiety covalently attached at the 5’ terminus of N2- (N’)y; and wherein each of Z and Z’ is independently present or absent, but if present is independently 1-5 consecutive nucleotides, consecutive non-nucleotide moieties or a combination thereof covalently attached at the 3’ terminus of the strand in which it is present; or a pharmaceutically acceptable salt of the double stranded nucleic acid molecule.
Patent NZ-599297-A (NZ)
Title: A computer system that assists a dispatcher talking to caller regarding a medical emergency of a patient by prompting the dispatcher to ask the caller diagnostic questions
Inventor: CLAWSON JEFFREY J
IPC: G16H50/80
Filed: 2010-07-27
Abstract: 599297 Disclosed is a computer-implemented method to assist a dispatcher (104) when communicating with a caller (118) via telephone (116) regarding a medical emergency of a patient. A dispatch center computer system (106) provides an emergency dispatch protocol (108) to assist the dispatcher (104) communicating with the caller (118). The protocol (108) presents a plurality of interrogatories for the dispatcher (104) to ask the caller (118) to collect information regarding the medical emergency and generate an emergency medical dispatch response by emergency responders based on the collected information. The dispatch center computer system (106) initiates a diagnostic tool (120) which is configured to aid the dispatcher (104) in uniformly collecting information about symptoms of a pandemic illness in a uniform consistent manner. The diagnostic tool (120) presents, to the dispatcher (104), a user interface and provides an instruction via the user interface for the dispatcher (104) to vocally relay to the caller (118) over the telephone to guide the caller in identifying symptoms of the pandemic illness that the patient is manifesting. The diagnostic tool (120) receives dispatcher-entered input that is indicative of information about symptoms of a pandemic illness gathered and relayed by the caller (118). The caller (118) relays the symptom information to the dispatcher (104) vocally over the telephone (116) and the diagnostic tool (120) collects symptom information from the dispatcher (104) entered input and compiles the symptom information into data having a uniform format that can be processed to monitor the spread of the pandemic illness. The dispatch center computer system (106) then transmits the collected symptom information to a data analyzing module that is configured to identify patterns and relationships within data received by the data analyzing module.
Patent NZ-599597-A (NZ)
Title: IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
Inventor: PASTOR-FERNANDEZ JOAQUIN
IPC: A61K31/5025
Filed: 2010-10-27
Abstract: Disclosed herein is are imidazo[1,2-b]pyridazine compounds of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inhibitors of the phosphodiesterase 10 enzyme (PDEI0) and as such are useful in the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved, such as schizophrenia, delusional disorder, schizo affective disorder, schizophreniform disorder and substance-induced psychotic disorder.
Patent NZ-612873-A (NZ)
Title: Intravenous pumping air management systems and methods
Inventor: DUDAR THOMAS
IPC: A61M5/38
Filed: 2011-12-28
Abstract: Disclosed is an intravenous liquid delivery system (10). The system comprises an intravenous pump tubing set (40), a pump actuator (20) operable with the intravenous pump tubing set, means for removing air, and an air detector (72) configured to sense air in the intravenous pump tubing set. The means for removing air may include an air passing but liquid retaining filter (see 76, figure 1), and/or a liquid passing air retaining filter (see 78, figure 2). A device for indicating whether the air detector is present and a control unit (12) may also be included.
Patent NZ-613091-A (NZ)
Title: Method and facility for treating water by nitrosation/denitrosation including at least an aeration step and a step for monitoring the oxygen supplied during the aeration step
Inventor: LEMAIRE ROMAIN
IPC: C02F3/12
Filed: 2011-12-23
Abstract: The disclosure relates to a method for treating water, containing nitrogen in the form of ammonium, within a biological reactor (10) by means of nitrosation/denitrosation, said method including at least a step (i) of feeding said water into said biological reactor (10), an aeration step (ii) during which oxygen is injected into the reactor (10), a step (iii) for extracting treated water from said reactor (10), determination steps being carried out continuously or intermittently at a predetermined frequency. Said method also includes a step of calculating the ratio between information representative of the quantity of nitrates formed in said reactor and information representative of the quantity of ammonium broken down in said reactor, and a step of determining the percentage of ammonium broken down in said reactor (10), the oxygen supplied to said reactor during said aeration step (ii) being predetermined on the basis of ratio between said information representative of the quantity of nitrates formed in said reactor (10) and said information representative of the quantity of ammonium broken down in said reactor (10), and on the basis of said percentage of ammonium broken down in said reactor (10).
Patent NZ-613118-A (NZ)
Title: Novel composition for the treatment of cystic fibrosis
Inventor: FREISSMUTH MICHAEL
IPC: A61K31/498
Filed: 2012-02-03
Abstract: Disclosed is a composition comprising at least one prostacyclin or prostacyclin analogue or a pharmaceutically acceptable salt thereof and at least one phosphodiesterase (PDE) 4 inhibitor for use in preventing or treating cystic fibrosis, wherein the prostacyclin analogue is selected from the group of Treprostinil, Iloprost, Cicaprost or Beraprost or pharmaceutically acceptable salts thereof.
Patent NZ-617528-A (NZ)
Title: Novel compound useful for the treatment of degenerative and inflammatory diseases
Inventor: MENET CHRISTEL JEANNE MARIE
IPC: C07D471/04
Filed: 2012-04-26
Abstract: The disclosure relates to the compound N-4-(3-fluoro-4-((4-(methylsulfonyl)piperazin-1-yl)methyl)phenyl)pyrazolo[1,5-a]pyridin-2-yl)acetamide (I) and pharmaceutical compositions comprising it. The disclosure also relates to the use of this compound for treatment or prophylaxis of allergy, inflammatory conditions, autoimmune diseases, proliferative diseases, transplant rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons. The autoimmune disease may be COPD, asthma, systemic lupus erythematosis, type I diabetes mellitus, psoriatic arthritis, ankylosing spondylitis, juvenile ideopathic arthritis, and inflammatory bowel disease and the inflammatory disease may be rheumatoid arthritis, osteoarthritis, asthma and inflammatory bowel diseases.
Patent NZ-705446-A (NZ)
Title: Method for differentiating between background and foreground of scenery and also method for replacing a background in images of a scenery
Inventor: VONOLFEN WOLFGANG
IPC: H04N9/75
Filed: 2011-08-16
Abstract: Disclosed is a method for differentiating between background and foreground of a scenery in images recorded by an electronic camera, the background showing an arbitrary image coded with a coding such that the image is visible for a direct observer of the background, and the background being differentiated from the non-coded foreground in a signal produced by an image sensor. The images of the camera are recorded by means of the coding which includes the background radiation letting through or reflecting electromagnetic radiation of at least one non-visible spectral range and a conversion device being disposed in front of the image sensor, which converts the nonvisible electromagnetic radiation into visible light which is detected by the image sensor.
Patent NZ-709925-A (NZ)
Title: Temperature stable cloquintocet-mexyl aqueous compositions
Inventor: HOPKINS DEREK J
IPC: A01P13/00
Filed: 2013-12-19
Abstract: Temperature stable aqueous compositions and methods for their preparation and use are described. The compositions can include cloquintocet-mexyl, a surfactant comprising a tallowamine alkoxylate, a cocoamine alkoxylate, or a combination thereof, and water.
Patent NZ-725004-A (NZ)
Title: An explosive booster
Inventor: VAN NIEKERK ALBERT PETRUS
IPC: F42C19/09
Filed: 2015-08-06
Abstract: An explosive booster (10) shaped to fit into a blasthole adjacent a main explosive charge is provided. The booster (10) comprises a body (12) containing a charge of an explosive substance (22) with a passage (24) extending inwardly of the body (12) to receive a detonator (26) therein. The booster (10) is configured to alter the shape of a detonation wave generated upon initiation of the detonator (26). In an embodiment, the booster (10) includes a first (32) and a second explosive substance (34), with the first explosive substance (32) being shaped and selected to cause an outer portion of the detonation wave to accelerate relative to the remainder of the wave thereby altering the shape of the wave from a generally spherical wave to a generally planar wave. In an embodiment, the booster includes an internal member capable of altering the shape of the detonation wave.
Patent NZ-727656-A (NZ)
Title: A variable behaviour control mechanism for a motive system
Inventor: DIEHL ANDREW KARL
IPC: B60R22/38
Filed: 2015-12-18
Abstract: Described herein is a variable behaviour control mechanism with a variety of motion characteristics, the mechanism comprising means to measure a plurality of motion characteristics and, where the mechanism activates when a threshold is reached to complete some manner of movement or movement prevention in response to the mechanism dynamics of movement, activation only occurring as a result of a plurality of characteristic of motion. The mechanism described is comparatively more complicated than art single motion characteristic measurement system like a vehicle seat belt and as a result may be used to for example, minimise or prevent unwanted activation yet operate with great accuracy when activation is required. A first mechanism is described where activation occurs between the at least one primary system and at least one secondary system when a combination of the sensed motion characteristics achieves a threshold. A second mechanism is described where activation occurs between the at least one primary system and at least one secondary system when at least one sensed motion characteristic achieves a threshold, the threshold being modified based on at least one further motion characteristic. A method of use of the above mechanisms is also described.
Patent NZ-732922-A (NZ)
Title: Tumor necrosis factor (tnf) superfamily receptor binding molecules and uses thereof
Inventor: BALIGA RAMESH
IPC: C07K14/705
Filed: 2016-01-20
Abstract: This disclosure provides dimeric, pentameric, and hexameric Tumor Necrosis Factor (TNF) superfamily receptor protein binding molecules and methods of using such binding molecules to direct apoptosis-mediated killing of TNF receptor-expressing cells. In particular, the present invention relates to a pentameric or hexameric IgM antibody comprising five or six bivalent binding units, wherein each binding unit comprises two IgM heavy chain constant regions each associated with an antigen-binding domain, wherein the IgM heavy chain constant regions each comprise a Cµ1 domain, a Cµ2 domain, a Cµ3 domain, and a Cµ4-tp domain; wherein at least three of the antigen-binding domains of the antibody specifically and agonistically bind to a tumor necrosis factor (TNF) superfamily receptor protein; wherein the antibody can cross-link at least three identical TNF superfamily receptor proteins expressed on the surface of a cell, thereby activating signal transduction in the cell; and wherein the antibody can activate TNF superfamily receptor-mediated signal transduction in a TNF receptor superfamily-expressing cell at a higher potency than an equivalent amount of a bivalent IgG1 antibody having the same antigen-binding domains, which also specifically binds to and agonizes the same TNF superfamily receptor protein.
Patent NZ-737830-A (NZ)
Title: Automatic press-fitting device for motor end covers and bearings
Inventor: ZHUBING SUN
IPC: H02K15/00
Filed: 2017-11-28
Abstract: The present invention discloses an automatic press-fitting device for a motor end cover and a bearing, comprising an end cover feed mechanism, a bearing feed mechanism and a bearing press-fitting mechanism; the end cover feed mechanism consists of an end cover pushing and separation mechanism and an end cover pickup and discharge mechanism; the end cover pushing and separation mechanism comprises an end cover fixation plate, an end cover guide plate and an end cover pushing block; the end cover pushing block is linked to an output end of a first linear motion device; left and right end cover limiting blocks are fixed on the end cover fixation plate; the end cover guide plate is fixed on an upper side of the end cover fixation plate; an end cover accommodating groove is formed on the end cover guide plate, which runs through the end cover guide plate in an up-and-down direction to accommodate motor end covers; motor end covers are arranged within the end cover accommodating groove in a stacked manner, and spacers are provided between adjacent motor end covers; the bottommost motor end cover is located between the two end cover limiting blocks, a lower end face of a spacer between two bottommost motor end covers is located below a lower end face of the end cover guide plate, and the second bottommost motor end cover is located within the end cover accommodating groove; a falling groove is formed on the end cover fixation plate, which runs through the end cover fixation plate in an up-and-down direction to allow the spacers to fall to a lower side of the end cover fixation plate; wherein a first sensor is provided at one end of the end cover fixation plate; when the first sensor detects that a motor end cover is pushed into the desired position; a second sensor is provided on the end cover pickup and discharge mechanism side; when the second sensor detects that the end cover feed mechanism places the motor end cover on the transfer plate, the second sensor transmits a signal to rotate the transfer plate. The automatic press-fitting device can realize the automatic press-fitting of motor end covers with bearings and can improve the production efficiency, reduce the labor cost and avoid the damage of components due to collision.
Patent NZ-749258-A (NZ)
Title: Cover film
Inventor: PIAZZI JÜRGEN
IPC: B32B27/08
Filed: 2017-05-31
Abstract: The invention relates to a cover film for fixing material when pressing round bales. The film comprises 5 to 50 weight % of a metallocene polyethylene (mPE-LLD) with a density of 0.886 to 0.935 g/cm3 in the inner layer (fig 1), and the outer layers of the film do not have any significant proportion of this copolymer.
Patent NZ-760499-A (NZ)
Title: Spark plug assembly
Inventor: D’ACOSTA CHRIS
IPC: H01T13/08
Filed: 2018-05-25
Abstract: A spark plug assembly configured to allow multi-channel automotive spark- plugs to operate without radio-frequency interference in piston-engine powered aircraft and to greatly reduce or eliminate spark-plug fouling from carbon or lead deposits resulting from combustion of fuel in order to enhance starting and smooth operation of the aircraft engine, and thereby improve the quality of exhaust emissions by assuring a more complete burn of the fuel constituents. The spark plug assembly having an external thread at one end and a terminal at the opposite end, the spark plug further including a hexagonal flange for use in rotating the spark plug to insert or remove the spark plug and a top insulator positioned between the hexagonal flange and the terminal; a housing comprising a sleeve having a first end defining an external thread sized and configured to couple with an ignition harness of a spark-ignited aircraft engine and a second end defining a hexagonal-shaped cavity sized and configured to receive the hexagonal flange of the spark plug, the top insulator and terminal of the spark plug being received within the sleeve and the hexagonal flange of the spark plug being received within the hexagonal-shaped cavity of the housing, the housing further defining an external hexagonal flange for use in securing the housing to the spark plug port of an aircraft engine; a coupling secured to the housing and including an internal thread configured to receive the external thread of the spark plug, the external thread of the spark plug being threadingly received within the internal thread of the coupling, the coupling further including an external thread configured to be received by the aircraft engine; and an insulator received within the sleeve and surrounding the top insulator of the spark plug.
Patent NZ-768221-A (NZ)
Title: Carton
Inventor: REQUENA EMILI
IPC: B65D5/22
Filed: 2019-04-02
Abstract: A carton for holding at least one article includes a plurality of panels that extends at least partially around an interior of the carton. The plurality of panels includes a bottom panel, a front panel, a back panel, at least one side panel, and a top panel. The carton further includes a tray formed from the bottom panel, the front panel, the back panel, and the at least one side panel, and the tray is for at least partially receiving the at least one article. The carton further includes a lid formed from the at least one top panel, the lid includes at least one article engaging feature for engaging the at least one article.